Dexcom G7 CEO Interview - Your Questions Answered

I had the opportunity to sit down with Dexcom CEO Kevin Sayer for an in-depth conversation about the future of continuous glucose monitoring (CGM) and where the company is headed next. We get into the development of a longer-wear G7 sensor, the challenges of expanding international access, and Dexcom’s vision for making CGM technology more accessible and user-friendly across all populations.

One of the biggest takeaways: a 15-day G7 is in the works and is expected in the second half of 2025. Sayer explained that while many users are eager for longer wear, Dexcom won’t release a new version until it meets their standards for safety, accuracy, and reliability across all age groups—including children. Extending the wear time involves more than just tweaking the label; it requires updates to sensor chemistry, algorithm stability, and adhesive performance to ensure it performs consistently from day 1 to day 15. It's coming—but only when it’s truly ready.

Watch the video podcast below and keep an eye out for all our diabetes updates by following along on TikTok, Instagram, and Youtube.

Go All In with Diabetech All Access + Get Exclusive Perks

If you’ve been finding value in these updates, deep dives, and real talk on diabetes tech—consider joining Diabetech All Access, our new premium membership for the most engaged members of the community.

Your membership directly supports our independent diabetes tech and research journalism and helps keep this newsletter going strong. In return, you'll unlock our exclusive content including:

• Industry trend reports you won’t find anywhere else

• Deeper hands-on reviews of the latest tech and tools

• Monthly Q&As, including Live sessions where you can ask your questions

By going All Access, you’re not just supporting the content—you’re becoming part of shaping the future of diabetes tech coverage. Thank you for your continued support!

✔️ Sign up for All Access here